ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol

New Option For Chronic Fatigue Syndrome

How Lipoic Acid Preserves Critical Mitochondrial Function

Living Longer, Healthier Lives with Resveratrol

Iodine: The Forgotten Medicine

Stop Bacteria With Nature's Antibiotics

Lipoic Acid Reverses Mitochondrial Decay

Nutraceutical Update - Rhodiola

Strengthen Cell Function with Energy-Boosting Niagen

Coenzyme Q10 Helps Veterans Battle Gulf War Illness Symptoms

 
Print Page
Email Article

ME/CFS Patients Demand FDA Bring Pharma and Clinical Experts to the Table

  [ 4 votes ]   [ Discuss This Article ]
By PANDORA • www.ProHealth.com • October 11, 2013


ME/CFS Patients Demand FDA Bring Pharma and Clinical Experts to the Table

Press release: GRAND RAPIDS, Mich., Oct. 10, 2013 /PRNewswire-USNewswire

PANDORA Org and many ME/CFS patients will participate in the FDA Chronic Fatigue Syndrome and Myalgic Encephalomyelitis (CFS and ME) Stakeholder teleconference on October 16 from 1:30 p.m.–3 p.m. EDT.  PANDORA Org's goal is to motivate the FDA to bring pharmaceutical and biotech companies to the table in a second workshop.  

"There are no FDA-approved therapies for this devastating disease, and patients need access to treatments now," said Lori Chapo-Kroger, RN, president and CEO of PANDORA Org. "Now that the FDA has a better understanding of the disease impact, as shown by their Patient Voice Report of their April meeting with patients, they need to open the drug development door wider so patients can find some relief from their suffering. To make this happen, the FDA needs to include the pharmaceutical companies and ME/CFS clinical experts in a workshop focused on developing outcome measures, what they failed to do in April."

In a September 2012 Report to the President on Propelling Innovation in Drug Discovery, Development, and Evaluation, President Barack Obama's Council of Advisors on Science and Technology states that the FDA should expand the scope of acceptable endpoints used to approve drugs for serious or life-threatening diseases with unmet needs.

"Certainly, this goal should be applied to drug development for ME/CFS, which the FDA classifies as a serious or life-threatening disease with unmet needs," said Chapo-Kroger.

The drug that has progressed furthest in the drug approval process is Ampligen, which has been in trials for decades. Rituximab is also showing promise in trials of ME/CFS patients. "The researchers and clinical experts involved in these studies are some of the top ME/CFS experts in the world and have the experience to know what outcome measures are best for ME/CFS drug trials," said Chapo-Kroger. "Leaving them out of an outcome measures discussion is a mistake and a tragedy for our patient community who are fighting to survive every day." 

After the background remarks, the FDA will open the teleconference discussion for public comments on the following three topics:

Feedback from the ME/CFS public workshop that was held April 25-26.

Current projects related to drug development in ME/CFS.

Potential methods to catalyze ME/CFS drug development.

The FDA's Patient-Focused Drug Development initiative is a commitment under the fifth authorization of the Prescription Drug User Fee Act (PDUFA V) that aims to more systematically gather patients' perspectives on their condition and available therapies to treat their condition.

The announcement of the October 16 teleconference can be found HERE.

Registration for the FDA call will be open until October 11, 2013. For more details, please go HERE

The September 2012 report to the president can be found HERE.


About PANDORA Org

PANDORA Org is a national nonprofit organization seeking to alleviate the suffering caused by neuro-endocrine-immune diseases (NEIDs), including ME/CFS, Fibromyalgia, chronic Lyme disease and Gulf War illnesses. For more information visit: www.pandoraorg.net

For More Information Contact

Lori Chapo-Kroger 

LoriKroger@pandoraorg.net 

231-360-6830

SOURCE PANDORA Org



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Immune Support Supplements

Featured Products

Vitamin D3 Extreme™ by ProHealth Vitamin D3 Extreme™ by ProHealth
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry
The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%
Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?
Shoo Pain, Don't Bother Me - Top 10 Nutrients to Take Back Your Life Shoo Pain, Don't Bother Me - Top 10 Nutrients to Take Back Your Life

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing